Drug Trial Radar · NCT05219617
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
252
Planned (sponsor's estimate)
Start
Apr 28, 2022
Primary completion
Feb 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- SK Life Science, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in pediatric and adult subjects (age 4-55 years) diagnosed with Lennox Gastaut Syndrome (LGS).
Conditions
- Seizures
- Lennox Gastaut Syndrome
Interventions
CarisbamateDrug
Adolescent subjects 12 to 18 years old will receive the same dose as adults. Subjects 4 to \< 12 years old in the carisbamate 200 mg BID arm will receive 4 mg/kg BID (not to exceed 200 mg BID \[or a total of 400 mg per day\]). Subjects 4 to \< 12 years old in the carisbamate 300 mg BID arm will receive 5.5 mg/kg BID (not to exceed 300 mg BID \[or a total of 600 mg per day\]).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary outcome will be the percentage change from baseline in the total frequency (average per 28 days) of countable drop seizures with potential to fall (tonic, atonic, tonic-clonic) seizures during the double-blind treatment period.Time frame: 3 years
Locations
71 sites in 16 countries. Site status is shown where the registry gives one.
Stanford University Hospital
Palo Alto, California · Recruiting
University of Florida Health Science Center
Jacksonville, Florida · Completed
AdventHealth
Orlando, Florida · Completed
Pediatric Epilepsy and Neurology Specialists
Tampa, Florida · Recruiting
University of South Florida
Tampa, Florida · Completed
Axcess Medical Research
Wellington, Florida · Completed
Consultants in Epilepsy and Neurology PLLC
Boise, Idaho · Completed
Bluegrass Epilepsy Research, LLC
Lexington, Kentucky · Completed
University Medical Center New Orleans
New Orleans, Louisiana · Completed
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland · Recruiting
Mayo Clinic
Rochester, Minnesota · Completed
University of Missouri School of Medicine
Columbia, Missouri · Completed
Northeast Regional Epilepsy Group
Hackensack, New Jersey · Recruiting
St. Peters Hospital
New Brunswick, New Jersey · Completed
Montefiore
The Bronx, New York · Completed
Duke University Clinical Research at Pickett Road
Durham, North Carolina · Recruiting
Wake Forest University - School of Medicine
Winston-Salem, North Carolina · Completed
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Austin Epilepsy Care Center - Clinic/Outpatient Facility
Austin, Texas · Completed
Neurology Consultants of Dallas, PA - Hospital
Dallas, Texas · Completed
Virginia Epilepsy and Neurodevelopmental Clinic at WNC
Winchester, Virginia · Completed
Hospital de Ninos de La Santisma Trinidad
Córdoba, Córdoba Province, Argentina · Completed
Resolution Psychopharmacology Research Institute
Mendoza, Mendoza Province, Argentina · Completed
Austin Hosptial
Heidelberg, Australia · Recruiting
Alfred Health
Melbourne, Australia · Recruiting
Perth's Children Hospital
Nedlands, Australia · Completed
Queensland Children's Hospital
South Brisbane, Australia · Completed
Fundacion Hospital Universidad del Norte
Barranquilla, Colombia · Withdrawn
Fundacion Valle del Lili/Clinic - Outpatient
Cali, Colombia · Withdrawn
CliniSalud del Sur S.A.S - Centro de Investigación
Envigado, Colombia · Completed
Hospital Pabloe Tubon Uribe
Medellín, Colombia · Completed
Institutio Neurologico de Colombia
Medellín, Colombia · Completed
Universitatsklinikum Erangen
Erlangen, Bavaria, Germany · Recruiting
Kleinwachau Sächsisches Epilepsiezentrum
Radeberg, Saxony, Germany · Recruiting
Iaso Children's Hospital
Marousi, Attica, Greece · Completed
Orszagos Mentalis, Ideggyogyaszati es Idegsebezeti Intezet
Budapest, Hungary · Completed
Semmelweis Egyetem Idegsebeszeti es Neurointervencios Klinika
Budapest, Hungary · Recruiting
Soroka University Medical Centre
Beersheba, Israel · Completed
Hadassah Medical Center
Jerusalem, Israel · Completed
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.